Evidence map›Paper›PMID 31249811›Full record

ArticleFrontiers in oncology2019

Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway.

Ma-Sha Huang, Jun-Yan Liu, Xiao-Bo Xia, Ying-Zi Liu, Xi Li, Ji-Ye Yin, Jing-Bo Peng, Lin Wu, Wei Zhang, Hong-Hao Zhou and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Construction and Analysis of circRNA-miRNA-mRNA Regulatory Networks.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Non-Coding RNAs as Key Regulators in Lung Cancer.International journal of molecular sciences · 2023
    Review
  14. Article
  15. Circular RNAs as biomarkers for lung cancer.Non-coding RNA research · 2023
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Ma-Sha HuangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Jun-Yan LiuDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Xiao-Bo XiaDepartment of Ophthalmology, Xiangya Hospital, Central South University, Changsha, China.
Ying-Zi LiuDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Xi LiDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Ji-Ye YinDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Jing-Bo PengDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Lin WuDepartment II of Thoracic Medicine, Hunan Cancer Hospital, Changsha, China.
Wei ZhangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Hong-Hao ZhouDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Zhao-Qian LiuDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Xiangya Hospital Central South University · CNCentral South University · CNPharmacoGenetics (China) · CNHunan Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

circular RNAcisplatin sensitivitycompeting endogenous RNAnon-small cell lung cancernucleotide excision repair signaling pathway

Identifiers

PMID31249811
PMCPMC6582772
OpenAlexW2949559296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.